PSMA PET/CT prior to salvage radiotherapy improves overall survival for prostate cancer patients: Real-world data from an entire country
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-Aug-2025 16:11 ET (13-Aug-2025 20:11 GMT/UTC)
Tuebingen, August 13, 2025. The DKMS Stiftung Leben Spenden is starting the new application round for the DKMS John Hansen Research Grant: up to four exceptional research projects by young scientists from around the world will be awarded funding of up to €240,000 each over three years. The projects to be funded should focus on hematopoietic stem cell transplantation and cell therapy for hematological diseases. Applications for the 2026 DKMS John Hansen Research Grant can be submitted until November 20, 2025.
Chimeric antigen receptor (CAR) T–cell immunotherapy reprograms a patient’s immune cells to target a cancer-specific cell surface protein. CAR T cells have been effective against blood cancers, but do not work as well in solid and brain tumors because cancer cells do not uniformly express the same cell surface proteins, allowing cancer cells to escape treatment and regrow the tumor.